24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
RedHill Biopharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:21
Former Mossad chief and real estate tycoons back controversial Israeli drone company
13:31
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
08:51
Jensen Huang: Nvidia “100% in Israel” despite war
21:56
Israel’s war with Iran costs up to $550 million a day
More stories
Buzz
Most popular
Daily
Weekly
1
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
2
Former Mossad chief and real estate tycoons back controversial Israeli drone company
3
Israel’s war with Iran costs up to $550 million a day
4
Israel orders airborne laser system for fighter jets and helicopters
5
Jensen Huang: Nvidia “100% in Israel” despite war
More news
RedHill Biopharma
2 stories about RedHill Biopharma
Israel’s RedHill Biopharma testing oral pill that cures Covid-19 symptoms
28.02.21
|
Yafit Ovadia
Israeli pharmaceutical company creates treatment to help severe and moderately-ill patients; company generates $90 million in sales annually
RedHill's Public Offering Spooks Investors, Sends Stock Down
09.11.17
|
Dror Reich
The Nasdaq-listed biopharmaceutical company priced its shares at $5.5 per American Depositary Share, a third of its 2015 public offering price, and dropped nearly 30% by Wednesday market close
